Total Payments
$20,127
2020 Payments
$55.24
Companies
4
Transactions
21
Medicare Patients
239
Medicare Billing
$9,774
Payment Breakdown by Category
Consulting$19,600 (97.4%)
Food & Beverage$181.91 (0.9%)
Other$151.20 (0.8%)
Travel$102.41 (0.5%)
Education$91.25 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $19,600 | 7 | 97.4% |
| Food and Beverage | $181.91 | 2 | 0.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $151.20 | 5 | 0.8% |
| Travel and Lodging | $102.41 | 6 | 0.5% |
| Education | $91.25 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $19,794 | 14 | $0 (2017) |
| Acorda Therapeutics, Inc | $151.20 | 5 | $0 (2018) |
| Celgene Corporation | $126.67 | 1 | $0 (2019) |
| Jazz Pharmaceuticals Inc. | $55.24 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $55.24 | 1 | Jazz Pharmaceuticals Inc. ($55.24) |
| 2019 | $126.67 | 1 | Celgene Corporation ($126.67) |
| 2018 | $121.20 | 4 | Acorda Therapeutics, Inc ($121.20) |
| 2017 | $19,824 | 15 | Teva Pharmaceuticals USA, Inc. ($19,794) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/24/2020 | Jazz Pharmaceuticals Inc. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $55.24 | General |
| Category: NEUROLOGY | ||||||
| 06/06/2019 | Celgene Corporation | Ozanimod (Drug) | Food and Beverage | In-kind items and services | $126.67 | General |
| 09/04/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $22.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 08/20/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $26.40 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 05/31/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $30.80 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 05/08/2018 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $42.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/11/2017 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $91.25 | General |
| 09/21/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Travel and Lodging | In-kind items and services | $18.94 | General |
| Category: Central Nervous System | ||||||
| 09/13/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Central Nervous System | ||||||
| 08/22/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Travel and Lodging | In-kind items and services | $12.31 | General |
| Category: Central Nervous System | ||||||
| 08/16/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Central Nervous System | ||||||
| 06/05/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Central Nervous System | ||||||
| 06/05/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Travel and Lodging | In-kind items and services | $17.12 | General |
| Category: Central Nervous System | ||||||
| 05/08/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Central Nervous System | ||||||
| 05/08/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Travel and Lodging | In-kind items and services | $18.73 | General |
| Category: Central Nervous System | ||||||
| 04/04/2017 | Acorda Therapeutics, Inc | AMPYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $30.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 03/20/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Central Nervous System | ||||||
| 02/20/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Central Nervous System | ||||||
| 02/20/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Travel and Lodging | In-kind items and services | $18.73 | General |
| Category: Central Nervous System | ||||||
| 01/16/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: Central Nervous System | ||||||
| 01/16/2017 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Travel and Lodging | In-kind items and services | $16.58 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 6 | 239 | 243 | $56,389 | $9,774 |
Total Patients
239
Total Services
243
Medicare Billing
$9,774
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 100 | 104 | $29,224 | $4,595 | 15.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 58 | 58 | $11,078 | $2,359 | 21.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 40 | 40 | $7,680 | $1,799 | 23.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 15 | 15 | $6,450 | $530.73 | 8.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 15 | 15 | $1,605 | $457.43 | 28.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 11 | 11 | $352.00 | $32.46 | 9.2% |
About Dr. Mark Lanser, MD
Dr. Mark Lanser, MD is a Neurology healthcare provider based in Janesville, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275574592.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Lanser, MD has received a total of $20,127 in payments from pharmaceutical and medical device companies, with $55.24 received in 2020. These payments were reported across 21 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($19,600).
As a Medicare-enrolled provider, Lanser has provided services to 239 Medicare beneficiaries, totaling 243 services with total Medicare billing of $9,774. Data is available for 1 year (2020–2020), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Sleep Medicine
- Location Janesville, WI
- Active Since 06/09/2006
- Last Updated 05/15/2012
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1275574592
Products in Payments
- COPAXONE (Drug) $19,702
- AMPYRA (Drug) $151.20
- Ozanimod (Drug) $126.67
- SUNOSI (Drug) $55.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.